Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara L Becker

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Pediatric Rheumatology Online Journal|May 2, 2021
Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling studyRyan S Funk, Valentina Shakhnovich, Yu Kyoung Cho, et al.
European Journal of Pharmacology|April 6, 2019
Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse modelRakesh K Singh, Leon van Haandel, Paul Kiptoo, et al.
Arthritis and Rheumatism|March 2, 2010
Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrationsMara L Becker, Leon van Haandel, Roger Gaedigk, et al.
British Journal of Clinical Pharmacology|June 30, 2021
A population physiologically-based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximabHsuan Ping Chang, Valentina Shakhnovich, Adam Frymoyer, et al.
Arthritis and Rheumatism|October 19, 2010
The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug responseMara L Becker, Roger Gaedigk, Leon van Haandel, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 9, 2018
Nicotinamide Phosphoribosyltransferase Deficiency Potentiates the Antiproliferative Activity of Methotrexate through Enhanced Depletion of Intracellular ATPRakesh K Singh, Leon van Haandel, Daniel P Heruth, et al.
Pharmacogenetics and Genomics|February 21, 2012
Red blood cell folate concentrations and polyglutamate distribution in juvenile arthritis: predictors of folate variabilityMara L Becker, Leon van Haandel, Roger Gaedigk, et al.
The Journal of Pediatrics|November 30, 2013
Methotrexate: new uses for an old drugPhilip J Hashkes, Mara L Becker, David A Cabral, et al.
ACR Open Rheumatology|November 29, 2019
Association of <i>SLCO1B1</i> *14 Allele with Poor Response to Methotrexate in Juvenile Idiopathic Arthritis PatientsLaura B Ramsey, Halima Moncrieffe, Chelsey N Smith, et al.
Metabolites|September 27, 2024
Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic ArthritisAmar Kumar, Joshua Tatarian, Valentina Shakhnovich, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Pediatric Rheumatology Online Journal|May 2, 2021
Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling studyRyan S Funk, Valentina Shakhnovich, Yu Kyoung Cho, et al.
European Journal of Pharmacology|April 6, 2019
Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse modelRakesh K Singh, Leon van Haandel, Paul Kiptoo, et al.
Arthritis and Rheumatism|March 2, 2010
Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrationsMara L Becker, Leon van Haandel, Roger Gaedigk, et al.
British Journal of Clinical Pharmacology|June 30, 2021
A population physiologically-based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximabHsuan Ping Chang, Valentina Shakhnovich, Adam Frymoyer, et al.
Arthritis and Rheumatism|October 19, 2010
The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug responseMara L Becker, Roger Gaedigk, Leon van Haandel, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 9, 2018
Nicotinamide Phosphoribosyltransferase Deficiency Potentiates the Antiproliferative Activity of Methotrexate through Enhanced Depletion of Intracellular ATPRakesh K Singh, Leon van Haandel, Daniel P Heruth, et al.
Pharmacogenetics and Genomics|February 21, 2012
Red blood cell folate concentrations and polyglutamate distribution in juvenile arthritis: predictors of folate variabilityMara L Becker, Leon van Haandel, Roger Gaedigk, et al.
The Journal of Pediatrics|November 30, 2013
Methotrexate: new uses for an old drugPhilip J Hashkes, Mara L Becker, David A Cabral, et al.
ACR Open Rheumatology|November 29, 2019
Association of <i>SLCO1B1</i> *14 Allele with Poor Response to Methotrexate in Juvenile Idiopathic Arthritis PatientsLaura B Ramsey, Halima Moncrieffe, Chelsey N Smith, et al.
Metabolites|September 27, 2024
Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic ArthritisAmar Kumar, Joshua Tatarian, Valentina Shakhnovich, et al.
Pageof 8